This podcast provides insight into our research process behind our recent published work on Danaher's Cytiva bioprocessing business. We explore:
How we approached studying bioprocessing
Bioprocessing's moats and customer switching costs
Why Cytiva has enjoyed ~80%+ market share for decades
Details of hypotheses we built throughout the process
How we sourced executives to interview
How we structured our written research